The prognostic significance of angiogenesis in epithelial ovarian carcinoma

Clinical Cancer Research

Volumn 5, Issue 3, 1999, Pages 587-591

  Alvarez, Angeles A ^a   Krigman, Hannah R ^a   Whitaker, Regina S ^a   Dodge, Richard K ^b   Rodriguez, Gustavo C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; MICROVASCULATURE; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

ADULT; AGED; CARCINOMA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0032995287     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ozols, R. F., and Rubin, S. C. Epithelial ovarian cancer. In: W. J. Hoskins (ed.), Principles and Practice of Gynecologic Oncology, p. 731. Hagerstown, MD: J. B. Lippincott Company, 1992.
2. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
3. Craft, P. S., and Harris, A. L. Clinical prognostic significance of tumour angiogenesis. Ann. Oncol., 5: 305-311, 1994.
4. Brem, S., Cotran, R., and Folkman, J. Tumor angiogenesis: a quantitative method for histologic grading. J. Natl. Cancer Inst., 48: 347-356, 1972.
5. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastatic correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
6. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E., Moore. D., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
7. Weidner, N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat., 36: 169-180, 1995.
8. Weidner, N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol., 147: 9-19, 1995.
9. Hollingsworth, H. C, Elise, C. K., Steinberg, S. M., Rothenberg, M. L., and Merino, M. J. Tumor angiogenesis in advanced stage ovarian carcinoma. Am. J. Pathol., 147: 33-41, 1995.
10. Abulafia, O., Triest, W. E., and Sherer, D. M. Angiogenesis in primary and metastatic epithelial ovarian carcinoma. Am. J. Obstet. Gynecol., 177: 541-547.
11. Miettinen, M., Lindenmayer, A. E., and Chaubal, A. Endothelial cell markers CD 31, CD34, and BNH9 antibody to H- and Y- antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod. Pathol., 7: 82-90, 1994.
12. Berchuck, A., and Akamel, A. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res., 50: 4087-4091, 1990.
13. Cox, D. R., and Lewis, P. A. W. The Statistical Analysis of Series of Events, p. 229. London: Chapman and Hall, Ltd., 1978.
14. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
15. Cox, D. R. Regression models and life tables. J. R. Stat. Soc., 34: 187-202, 1972.